Bicyclic Compound, Production and Use Thereof
AssigneeTobira Therapeutics, Inc.
InventorsMitsuru SHIRAISHI, Masanori BABA, Katsuji AIKAWA, Naoyuki KANZAKI, Masaki SETO, Yuji IIZAWA
Life of this patent
Estimating the term…
Loading patent…
AssigneeTobira Therapeutics, Inc.
InventorsMitsuru SHIRAISHI, Masanori BABA, Katsuji AIKAWA, Naoyuki KANZAKI, Masaki SETO, Yuji IIZAWA
Estimating the term…
The present invention provides a new cyclic compound having a CCR antagonist activity, especially a CCR5 antagonist activity, and the use thereof. The compound of the present invention is represented by the formula: wherein, R1 is a 5- to 6-membered ring group which may be substituted; X1 is a bond or the like; ring A is a 5- to 6-membered ring group which may be substituted; ring B is a 8- to 10-membered ring group which may be substituted; X2 is a bivalent group of 1 to 4 atoms; Z1 is a bivalent cyclic ring group or the like; Z2 is a bond or the like; and R2 is an amino group, a nitrogen-containing heterocyclic group which may be substituted or the like, or a salt thereof.
A compound of the formula:
A compound of the formula:
-27. (canceled)
A CCR antagonist pharmaceutical composition comprising a compound of the formula:
A method for antagonizing CCR5 which comprises administering an effective amount of a compound of the formula:
A method for preventing or treating HIV infectious disease, chronic rheumatoid arthritis, autoimmune disease, allergic disease, ischemic brain cell disorder, cardiac infarction, chronic nephritis or arteriosclerosis which comprises administering an effective amount of a compound of the formula:
A method for preventing or treating graft versus host disease and/or rejection in case of organ or bone marrow transplantation which comprises administering an effective amount of a compound of the formula:
A method for preventing HIV infectious disease in case of transfusion or using blood derivatives which comprises administering an effective amount of a compound of the formula:
A process for producing blood for transfusion or blood derivatives prevented or inhibited from infection of HIV virus and proliferation thereof which comprises compounding the blood for transfusion or blood derivatives with a compound of the formula:
A method for preventing or inhibiting infection of HIV virus and proliferation thereof in blood for transfusion or blood derivatives which comprises compounding the blood for transfusion or blood derivatives with a compound of the formula:
-56. (canceled)
Dependencies are inferred from the claim text.